393 related articles for article (PubMed ID: 30087232)
1. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
Yu J; Liu SL
Viruses; 2018 Aug; 10(8):. PubMed ID: 30087232
[TBL] [Abstract][Full Text] [Related]
2. IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication.
Meischel T; Fritzlar S; Villalon-Letelier F; Tessema MB; Brooks AG; Reading PC; Londrigan SL
J Virol; 2021 Sep; 95(20):e0083721. PubMed ID: 34319159
[TBL] [Abstract][Full Text] [Related]
3. The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.
Wang Y; Pan Q; Ding S; Wang Z; Yu J; Finzi A; Liu SL; Liang C
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100616
[TBL] [Abstract][Full Text] [Related]
4. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
Chen Z; Gettie A; Ho DD; Marx PA
Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
[TBL] [Abstract][Full Text] [Related]
5. Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.
Wang B; Lam TH; Soh MK; Ye Z; Chen J; Ren EC
Front Immunol; 2018; 9():1193. PubMed ID: 29904383
[TBL] [Abstract][Full Text] [Related]
6. Interferon-Induced Transmembrane Proteins Inhibit Infection by the Kaposi's Sarcoma-Associated Herpesvirus and the Related Rhesus Monkey Rhadinovirus in a Cell-Specific Manner.
Hörnich BF; Großkopf AK; Dcosta CJ; Schlagowski S; Hahn AS
mBio; 2021 Dec; 12(6):e0211321. PubMed ID: 34933450
[TBL] [Abstract][Full Text] [Related]
7. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
[TBL] [Abstract][Full Text] [Related]
8. Δ20 IFITM2 differentially restricts X4 and R5 HIV-1.
Wu WL; Grotefend CR; Tsai MT; Wang YL; Radic V; Eoh H; Huang IC
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7112-7117. PubMed ID: 28630320
[TBL] [Abstract][Full Text] [Related]
9. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.
Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB
Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692
[TBL] [Abstract][Full Text] [Related]
10. The IFITM proteins inhibit HIV-1 infection.
Lu J; Pan Q; Rong L; He W; Liu SL; Liang C
J Virol; 2011 Mar; 85(5):2126-37. PubMed ID: 21177806
[TBL] [Abstract][Full Text] [Related]
11. Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.
Blyth GA; Chan WF; Webster RG; Magor KE
J Virol; 2016 Jan; 90(1):103-16. PubMed ID: 26468537
[TBL] [Abstract][Full Text] [Related]
12. Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
Foster TL; Wilson H; Iyer SS; Coss K; Doores K; Smith S; Kellam P; Finzi A; Borrow P; Hahn BH; Neil SJD
Cell Host Microbe; 2016 Oct; 20(4):429-442. PubMed ID: 27640936
[TBL] [Abstract][Full Text] [Related]
13. Co-receptors for HIV-1 entry.
Moore JP; Trkola A; Dragic T
Curr Opin Immunol; 1997 Aug; 9(4):551-62. PubMed ID: 9287172
[TBL] [Abstract][Full Text] [Related]
14. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
[TBL] [Abstract][Full Text] [Related]
15. Alphavirus Restriction by IFITM Proteins.
Weston S; Czieso S; White IJ; Smith SE; Wash RS; Diaz-Soria C; Kellam P; Marsh M
Traffic; 2016 Sep; 17(9):997-1013. PubMed ID: 27219333
[TBL] [Abstract][Full Text] [Related]
16. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
Yu J; Liang C; Liu SL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor.
Chen J; Dang Q; Unutmaz D; Pathak VK; Maldarelli F; Powell D; Hu WS
J Virol; 2005 Apr; 79(7):4140-9. PubMed ID: 15767415
[TBL] [Abstract][Full Text] [Related]
18. Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.
Joseph SB; Arrildt KT; Swanstrom AE; Schnell G; Lee B; Hoxie JA; Swanstrom R
J Virol; 2014 Feb; 88(4):1858-69. PubMed ID: 24307580
[TBL] [Abstract][Full Text] [Related]
19. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1.
Yi Y; Rana S; Turner JD; Gaddis N; Collman RG
J Virol; 1998 Jan; 72(1):772-7. PubMed ID: 9420285
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
